Cheng-Yang Chou
Papers
1
Total Citations
10
H-Index
1
About
Cheng-Yang Chou is a leading clinical researcher in gynecologic oncology, with a particular focus on ovarian, tubal, and peritoneal cancers. His most prominent work, the ROBOT study (2020), provides critical real-world evidence on the long-term efficacy and safety of adding bevacizumab to chemotherapy in Asian patients. This eight-year retrospective analysis, cited 10 times, offers invaluable insights into prognostic impacts and adverse effects beyond controlled clinical trials, directly informing treatment strategies for a population often underrepresented in global research. Chou’s contributions bridge the gap between trial data and clinical practice, helping to optimize front-line and relapse therapy for these challenging malignancies. His work is essential reading for oncologists and researchers seeking to understand the nuanced, long-term outcomes of targeted therapies in diverse patient cohorts.
Research Focus
Key Achievements
Top Papers
- 1